Development and validation of the ADHD Symptom and Side Effect Tracking - Baseline Scale (ASSET-BS): a novel short screening measure for ADHD in clinical populations
Joel Young(Dalhousie University), Ashley Ceresnie(Rochester Center for Behavioral Medicine), Jillian Fortain(Rochester Center for Behavioral Medicine), Celeste Zabel(Henry Ford Health System), Richard N. Powell(Rochester Center for Behavioral Medicine), Lisa L. M. Welling(Oakland University), Jaime Saal(Rochester Center for Behavioral Medicine)
Cited by 4
Related Papers
Sexual selection on male vocal fundamental frequency in humans and other anthropoids
|Proceedings of the Royal Society B Biological Sciences|2016|186
Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
|CNS Spectrums|2009|93
A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder
|Journal of the American Academy of Child & Adolescent Psychiatry|2015|63
Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder
|Clinical Neuropharmacology|2011|61